Company · CIK 1843762
EQRx, Inc.
| CIK | 1843762 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-05-26 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-261786 | 2021-12-21 | 2023-11-17 | 4 | |
| 333-269972 | 2023-02-23 | 2023-11-17 | 3 | |
| 333-269973 | 2023-02-23 | 2023-11-17 | 3 | |
| 333-253475 | 2021-02-25 | 2021-04-08 | 4 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-11-17 | EFFECTDeclared effective | 333-269973 | 9999999995-23-003374 |
| 2023-11-17 | EFFECTDeclared effective | 333-269972 | 9999999995-23-003373 |
| 2023-11-17 | EFFECTDeclared effective | 333-261786 | 9999999995-23-003369 |
| 2023-03-03 | EFFECTDeclared effective | 333-269973 | 9999999995-23-000515 |
| 2023-03-03 | EFFECTDeclared effective | 333-269972 | 9999999995-23-000514 |
| 2023-02-23 | S-3Shelf registered | 333-269973 | 0001104659-23-024837 |
| 2023-02-23 | S-3Shelf registered | 333-269972 | 0001104659-23-024835 |
| 2022-03-28 | EFFECTDeclared effective | 333-261786 | 9999999995-22-000733 |
| 2021-12-23 | EFFECTDeclared effective | 333-261786 | 9999999995-21-004818 |
| 2021-12-21 | S-1Registration filed | 333-261786 | 0001213900-21-066498 |
| 2021-12-01 | EFFECTDeclared effective | 333-259054 | 9999999995-21-004524 |
| 2021-04-08 | 424B4Final prospectus | 333-253475 | 0001213900-21-020818 |
| 2021-04-06 | EFFECTDeclared effective | 333-253475 | 9999999995-21-001298 |
| 2021-03-25 | S-1/AAmendment | 333-253475 | 0001213900-21-017805 |
| 2021-02-25 | S-1Registration filed | 333-253475 | 0001213900-21-011439 |